Biological basis of anemia
References (36)
- et al.
Anaemia in cancer: Pathophysiology and treatment
Cancer Treat Rev
(2000) - et al.
The use of recombinant human erythropoietin in the correction of anemia in predialysis patients and its effect on renal function: A double-blind, placebo-controlled trial
Am J Kidney Dis
(1989) Erythropoietin for anaemia in cancer patients
Eur J Cancer
(1993)- et al.
Erythropoietin treatment for chronic anemia of selected hematological malignancies and solid tumors
Ann Oncol
(1993) - et al.
An analysis of potential factors allowing an individual prediction of cisplatin-induced anaemia
Eur J Cancer
(2000) The blood in systemic disorders
Lancet
(2000)- et al.
Hematopoiesis and cytokines. Relevance to cancer and aging
Hematol Oncol Clin North Am
(2000) - et al.
Effect of inflammatory cytokines on hypoxia-induced erythropoietin production
Blood
(1992) - et al.
Prediction of response to erythropoietin treatment in chronic anemia of cancer
Blood
(1994) - et al.
Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group
J Clin Oncol
(1997)
Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: Results from a prospective community oncology study. Procrit Study Group
J Clin Oncol
(1998)
Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: Results of a randomized, double-blind, placebo-controlled trial
J Clin Oncol
(2001)
Erythropoietin therapy in cancer patients
Oncology
(1991)
Expression of the erythropoietin gene
Mol Cell Biol
(1986)
Anemia induces accumulation of erythropoietin mRNA in the kidney and liver
Mol Cell Biol
(1986)
Erythropoietin
N Engl J Med
(1991)
Correction of anaemia of chronic renal failure with recombinant human erythropoietin: Safety and efficacy of one year's treatment in a European multicentre study of 150 haemodialysis-dependent patients
Nephrol Dial Transplant
(1989)
The quality of life of hemodialysis recipients treated with recombinant human erythropoietin. Cooperative Multicenter EPO Clinical Trial Group
JAMA
(1990)
Cited by (0)
- 1
Prof Bron has received honoraria from Ortho Biotech and Janssen-Cilag.
Copyright © 2001 Published by Elsevier Inc.